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INTRODUCTION 
Diabetes mellitus (DM) connotes a 
metabolic disorder characterized by chronic 
hyperglycemia which arises as a result of 
disturbance in carbohydrate metabolism 
caused by the deficiency of β-cells in the 
pancreas.
1
 The global prevalence of diabetes 
is about 7.8% and if it is not checked, about 
438 million people will be suffering from 
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ABSTRACT 
Background and aims: This study investigates the kinetics of inhibitory activities of 
ethyl acetate leaf fraction of Lecanodiscus cupanoides on 𝛼-amylase and 𝛼-glucosidase. 
Methods: This was done using 𝛼-amylase and 𝛼-glucosidase enzymes from Aspergillus 
oryzae and Saccharomyces cerevisiae respectively, active component and antioxidants 
capabilities of the fraction were also analyzed. 
Results: The fraction scavenged DPPH, OH*, and ABTS
+
 and chelated Fe
2+ 
with the IC50 
values of 0.46, 0.70, 0.75 and 0.97 mg/mL respectively. However, significant and mild 
inhibitory effect was also observed in 𝛼- amylase and glucosidase with IC50 values (0.73 
and 0.58 mg/mL) in concentration dependent pattern. Kinetic analysis of the fraction 
revealed an uncompetitive and non-competitive mode of inhibition for 𝛼-amylase 
and 𝛼-glucosidase respectively. 
Conclusion: This study suggests that ethylacetate fraction of this plant possesses 
antidiabetic property as a result of its ability to inhibit the metabolism of 
carbohydrate hydrolyzing enzymes. The elicited activities of the ethyl acetate 
fraction Lecanodiscus cupanoides may be due to the presence of phytochemicals 
of utmost pharmacological importance present in the fraction. 
 
Keywords: Acarbose, Diabetes, Hyperglycemia, Postprandial Hyperglycemia, Radical 
Scavenging. 
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this disorder by 2030.
2
 In Africa, the 
prevalence of DM is very high in South 
Africa and Nigeria with 8.30% and 4.50%, 
respectively.
3
 Reduction of postprandial 
(PP) hyperglycemia is one of the therapeutic 
interventions for the treatment of DM. This 
can be done by retarding the uptake of 
glucose in the digestive tract though the 
inhibition of carbohydrate hydrolyzing 
enzymes (α-amylase and glucosidase).4 
α-amylase inhibitors are often called 
starch blockers as a result of their ability to 
delay the absorption of dietary starch by the 
body which eventually lower blood glucose 
through the inhibition of an enzyme such as 
salivary and pancreatic amylase.
5
 However, 
α-glucosidase inhibitors suppress PH in  
the intestine by completely and reversibly 
inhibiting the enzyme (α-glucosidase), 
which in turn minimizes glucose absorption 
through delayed carbohydrate catabolism 
and extended digestion time.
6
 
Reactive oxygen species (ROS) is a key 
to the development of DM.
7
 Excessive activity 
of ROS is physiologically related to the 
development of postprandial hyperglycemia.
8
 
The rise in ROS in DM patients occurs 
through glucose auto-oxidation which leads  
to production of free radicals, imbalance 
cellular reduction/oxidation and inhibition of 
scavenging activity of the enzymes against 
free radicals.
9,10
 
The management of DM with little or 
no side effects is still a challenge to the 
pharmacologist. The use of herbs derived 
drugs in the treatment of this disorder has 
increased significantly in the recent time. 
The efficacy and lesser therapeutic side 
effects pose by herbal drugs has established 
a novel anti-diabetic therapy.
11
 However, it 
has been established that botanicals with 
radical scavenging ability could be useful 
in the management of DM. In view of  
the foregoing assertions, Lecaniodiscus 
cupanioides (LC) is one of the botanicals 
with antidiabetic potential owing to its 
effectiveness in radical scavenging. 
LC belongs to the family of sapindaceae, 
it’s popularly used in South West Nigeria for 
the treatment of array of ailments such as 
tooth ache, fever, wounds, boils, burns and 
bruises.
12,13
 Pharmacological studies have 
revealed LC to possess activities such as 
antimicrobial, hepatoprotective property, and 
radical scavenging activity on kidney, liver 
and brain enzymes.
14-17
 However, no study 
has been conducted to investigate the 
antidiabetic activity of the leaves of LC. 
Therefore, this study was carried out to 
elucidate the inhibitory effect of ethyl 
acetate fraction of Lecaniodiscus cupanioides 
(EFLC) on α-amylase and glucosidase which 
are two key enzymes that is linked to 
carbohydrate metabolism in the body and its 
mechanism of action using in vitro model. 
 
METHODS 
Fresh leaves of LC were collected 
around Esindale area, Ile-Ife, Osun State 
Nigeria, authenticated by MrAdemoriyo 
G.A of the IFE herbarium with voucher 
specimen (IFE7492) deposited to the 
herbarium. The leaf sample was air-dried 
at room temperature until constant weight 
and ground. The powered sample (750 g) 
was soaked and extracted in methanol/ 
distilled water (3: 2 v/v) for four days with 
regular agitation at intervals. This was 
thereafter filtered and the filtrate was 
concentrated in vacuo and lyophilized. The 
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yield obtained was 130 g. A portion (20 g) 
of the leaves extract was reconstituted in 
distilled water (150 mL) and then 
partitioned into ethyl acetate fraction. The 
dried fraction was reconstituted in 
dimethyl sulphoxide (1 mg/mL) and used 
for all the analyses. Similarly, a stock 
concentration of 1 mg/mL was also 
prepared for acarbose and garlic acid. 
EFLC was then subjected to qualitative 
phytochemical screening for detection of 
alkaloids, anthraquinones, glycosides, 
flavonoids, phenols, saponins, triterpenes, 
phytosterols and sterols.
18,19
 For quantitative 
phytochemical analysis,total phenolic content 
was done by mixing 1 mL of the EFLC  
(1 mg/mL)  with Folin-Ciocalteu reagent  
(5 mL) and 75g/1000 mL of sodium carbonate 
(4 mL) in a tube. For colour development, the 
resulting mixture was vortexed (15 s) and 
subsequently incubated (40 °C, 30 min). 
Afterwards, the absorbance of the mixture was 
spectrophotometrically taken (Biochrom WPA 
Biowave II, Cambridge) at 765 nm. The 
determinations were triplicated in each case. 
Using garlic acid as standard, the phenolic 
content of the EFLC was estimated from its 
calibration curve and expressed as %w/w 
garlic acid equivalent.
20
 
To determine flavonoid content, equal 
portion (0.5 mL each) of alcoholic 
aluminum solution (2%) and the EFLC  
(1 mg/mL) were mixed in a test tube prior to 
incubation (25 °C, 1 h). Subsequently, the 
absorbance was taken at 420 nm and the 
flavonoid content was expressed as quercetin 
equivalent using its (quercetin) standard 
calibration curve.
21
 For the estimation total 
flavanol, the rutin calibration curve was 
prepared by mixing 2000 µL of different 
concentrations (200-1000 µg/mL) of rutin 
with 2000 µL (20 g/L) aluminum chloride 
and 6000 µL (50 g/L) sodium acetate in test 
tubes. Following incubation (20 °C, 2.5 h), 
the absorbance was read at 440 nm. The 
determinations were carried out in triplicates 
and the protocol was also performed with 
2000 µL of the EFLC (100/ 1000 µg/mL) 
instead of rutin solution. The total flavonols 
in the EFLC was thereafter estimated from 
rutin standard curve.
22
 
To determine DPPH radical scavenging 
potential of the fraction, different 
concentrations (200-1000 µg/mL) of EFLC 
and methanolic garlic acid solutions were 
mixed with methanolic solution of DPPH 
(0.2 M). Following 30 min of incubation  
(25 °C), the absorbance of the resulting 
solutions were colorimetrically determined 
against blank at 517 nm.
23
 For Metal 
chelating assay, 0.1 mL of either garlic acid 
or the samples (0.2-1.0 mg/mL) was added 
to 0.2 mM ferrous chloride solution  
(0.5 mL). To initiate the reaction, 5 Mm 
Ferro zine (0.2 mL) was added and the 
mixture incubated (25 °C, 10 min). The 
absorbance of the resulting solution was 
then taken against blank at 562 nm.
24
 
For ABTS radical determination, 50 mL 
each of 7 M ABTS and 2.45 mM potassium 
persulphate were mixed and incubated for 16 h 
in the dark. Subsequently, the concentration of 
solution was spectrophotometrically (734 nm) 
adjusted to 0.700 using ethanol. A portion  
(20 µL) of the EFLC (0.2-1.0 mg/mL) was 
thereafter reacted with the resulting ABTS 
solution (200 µL) in a 96-well microtiter plate 
prior to incubation (25 °C, 15 min) and final 
absorbance reading (734 nm) in a microplate 
reader (Model 680 BIO-RAD, USA).25 
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Hydroxyl radical scavenging activity 
(OH*) was determine by adding  0.1 mL of 
EFLC (0.2-1.0 mg/mL) to a reaction 
medium containing 20 mM deoxyribose 
(0.12 mL), 0.1 M phosphate buffer (0.4 mL), 
20 mM hydrogen peroxide (0.04 mL) and 
500 µM ferrous sulphate (0.04 mL). 
Following this, sterile distilled water  
(0.1 mL) was added and the resulting 
solution incubated (37 °C, 30 min). To bring 
the reaction to a halt, 0.5 mL of 2.8% 
trichloroacetic acid and 0.4 mL of 0.6% 
thiobarbituric acid solutions were added. 
Thereafter, a portion (0.3 mL) was taken and 
dispensed into a 96-well microtiter plate, 
boiled for 20 min prior to absorbance 
reading at 532 nm.
26
 
For each of the antioxidant assay, the 
experiment was conducted in triplicate, 
inhibition/ scavenging rate (I %) was 
calculated using the expression: 
 
Percentage inhibition (I %)= (A control-A fraction) 
/A control] ×100 
 
Where A control is the absorbance of the 
control, A fraction is the absorbance of the 
fraction. The concentration of the fraction 
and garlic acid causing 50% inhibition (IC50) 
for all the assays was estimated using 
standard calibration curve. 
In the α-amylase inhibitory assay, 
varying concentrations (0.2-1.0 mg/mL) of 
the fraction and acarbose (control) were 
prepared and 500 mL of each was mixed 
with 500 mL of 0.02 M sodium phosphate 
buffer (pH 6.9) containing 0.5 mg/mL of  
α-amylase solution and incubated (25 °C,  
10 min). After initial incubation, 500 mL of 
1% starch solution in 0.02 M sodium 
phosphate buffer (pH=6.9) was added to 
each tube at timed intervals. The reaction 
mixtures were incubated (25 °C, 10 min) 
and stopped with 1.0 mL of dinitrosalycyclic 
acid colour reagent. The tubes were  
then incubated in a boiling water bath for  
5 min and subsequently cooled to room 
temperature. The reaction mixtures were 
then mixed with distilled water (15 mL),  
and the absorbance readings were taken  
(540 nm) using a spectrophotometer 
(Biochrom WPA Biowave II, Cambridge) 
and the values compared with a control 
which contained 500 mL of the buffer 
instead of the fraction.
27,28
 
For α-amylase kinetics study, EFLC 
was incubated with 5 mg/mL α-amylase 
with the starch concentration varied from 
0.016-0.200 mg/mL. The reaction was then 
allowed to proceed as highlighted above. 
Maltose standard curve was used to 
determine the amount of reducing sugars 
released spectrophotometrically, before it  
is converted to reaction velocities (v).  
Line- weaver-Burk double reciprocal plot 
(1/v versus 1/[S]) was constructed and the 
kinetics of α-amylase inhibition by the 
extract was determined (Lineweaver and 
Burk 1934).
29
 
α-glucosidase glucosidase inhibitory 
potential of EFLC was determine by adding 
50 mL from the stock solution with 100 mL 
of 0.1 M phosphate buffer (pH=6.9) 
containing 1.0 m of α-glucosidase solution. 
The mixtures were then incubated in 96-well 
plates at 25 °C for 10min. Following this,  
50 mL of 5mM p-nitrophenyl-α-D-
glucopyranoside solution in 0.1 phosphate 
buffer (pH=6.9) was added to each well at 
timed intervals. The reaction mixtures were 
Advanced Herbal Medicine, 2017; 3(1): 37-51. 
41 
incubated (25 °C, 5 min) before the 
absorbance was taken using microplate 
reader (405 nm). The absorbances were 
compared with a control which contained  
50 mL of the buffer. Acarbose was prepared 
in distilled water at same concentrations as 
the fraction and used as control.
28,30
 For the 
enzyme kinetics of α-glucosidase activity by 
EFLC, 50 μL of 5mg/mL EFLC was initially 
incubated with100 μL of α-glucosidase 
solution (10min, 25 °C ) in one group of tubes. 
In another separate group of tubes,  
α-glucosidase was pre-incubated with 50 μL 
of phosphate buffer (pH=6.9). 50 mL of 
pNPG at varying concentrations (0.016-0.2 
mg/mL) was added to both groups of 
reaction mixtures to start the reaction. The 
mixture was then incubated (10 min, 25 °C) 
and 500 mL of Na2CO3 was added to halt 
the reaction. P-nitrophenol standard curve 
was used to evaluate the amount of reducing 
sugar released. Reaction rates (v) were then 
calculated and double reciprocal plots  
(1/v versus 1/[S]) of enzyme kinetics were 
constructed to study the nature of inhibition 
(Lineweaver and Burk, 1934).
31
 Km and 
Vmax values were also calculated from  
the curve. 
The experiments were conducted in 
triplicate and the α-amylase inhibitory 
activity was expressed as % inhibition. 
Using the expression: 
% inhibition= [(ΔAcontrol - ΔAfraction)/ 
ΔAcontrol] ×100, where Δ Acontrol and 
ΔAfraction are the changes in absorbances 
of the control and fraction respectively. 
Using standard calibration curve, the 
concentration of EFLC causing 50% 
inhibition (IC50) of the activity was 
estimated. 
Antioxidant potentials were presented 
as percentage (%). The remaining data were 
presented as mean ± standard deviation (SD) 
of replicate experiments. The data were 
analyzed using analysis of variance  
(one- way) complemented with Duncan 
multiple range test (Statistical Analysis 
System (SAS) Model 9.13) to detect 
significant differences between mean values. 
Differences were considered significant at 
P<0.05 confidence interval value. 
 
RESULTS 
The preliminary phytochemical 
screening of EFLC reveals the presence of 
Alkaloid, phenol, saponin, tannin, cardiac 
glycosides, steroids, phytosterol and 
flavonoids (Table 1). 
 
Table 1: Phytochemical constituents of EFLC 
Phytochemicals Remark 
Alkaloid Detected 
Flavanoid Detected 
Cardiac glycoside Detected 
Phenol Detected 
Anthraquinone Not detected 
Tannin Not Detected 
Saponin Detected 
Triterpene Not Detected 
Phytosterol Detected 
Steroids Detected 
 
The total phenol, flavonoid and flavonol 
were 62.41 ± 5.01 %w/w, 47.68 ± 3.97 
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%w/w and 20.49 ± 1.62 %w/w respectively 
(Table 2). 
 
Table 2: Total phenolic, ﬂavonoid, and 
ﬂavonol contents EFLC 
Phytochemicals EFLC 
Phenol (%w/w) 62.41 ± 5.01 
Flavonoid (%w/w) 47.68 ± 3.97 
Flavonol (%w/w) 20.49 ± 1.62 
Values were expressed in % w/w of plant extracts and 
are means of triplicate determinations ± Standard 
deviation. 
 
The in vitro activity of the ethyl ethanoate 
fraction is presented in Figure 1-4. The 
fraction exerts its antioxidant activities in dose 
dependent manner. For the ABTS+, the fraction 
demonstrated a very strong scavenging ability 
against 3-ethylbenzothiazoline-6-sulphonic acid 
cation chromophore when compared with 
garlic acid judging from its IC50 value  
(0.75 mg/mL) which is not significantly 
different from that of the standard. However, 
DPPH scavenging ability of the fraction is 
significantly potential when compared with 
garlic acid (Table 3). 
Gallic acid showed significant effect 
on metal chelating and hydroxyl radical 
scavenging, though that of the fraction was 
also commendable judging from its IC50 
values (Table 3). 
 
 
Figure 1: ABTS scavenging effect of EFLC 
Values are mean ± standard deviation (SD) of triplicate determinations. 
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Figure 2: DPPH scavenging effect of EFLC 
Values are mean± standard deviation (SD) of triplicate determinations. 
 
 
Figure 3: Hydroxyl radical scavenging potential EFLC 
Values are mean ± standard deviation (SD) of triplicate determinations. 
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Figure 4: Iron chelation potential of EFLC 
Values are mean± standard deviation (SD) of triplicate determinations. 
 
Table 3: IC50 (mg/mL) with R
2
 and Regression equation of ABTS, DPPH, Hydroxyl radical 
scavenging and metal chelating abilities of EFLC 
The values are expressed as mean of triplicate determinations; Means along the rows not sharing a common 
superscript are significantly different (P<0.05) from each other; Gallic acid is the standard antioxidant agent. 
 EFLC Garlic Acid 
 
ABTS 
IC50 0.75
a
 0.79
 a
 
R
2
 0.9990 0.9347 
Regression equation Y=59.2650x + 5.8390 Y=42.6850x + 16.1730 
 
DPPH 
IC50 0.46
 a
 0.53
b
 
R
2
 0.9272 0.8964 
Regression equation Y=74.2350x + 15.8230 Y=70.6000x + 12.3700 
 
Hydroxyl Radical 
Scavenging 
IC50 0.70
 a
 0.55
 b
 
R
2
 0.8656 0.9515 
Regression equation Y=30.2450x + 28.7190 Y=33.6850x + 31.8150 
 
Metal chelating 
IC50 0.97
 a
 0.42
 b
 
R
2
 0.9878 0.9562 
Regression equation 29.2800x + 21.6660 69.8550x + 19.9880 
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Figure 5 and 6 shows the inhibitory 
effects of EFLC on α-amylase and 
glucosidase. The inhibition of α-amylase and 
glucosidase was dose dependent, the most 
potent activity was observed with the fraction 
at the highest concentration, while the lowest 
concentration of 0.20 mg/mL revealed 
minimum inhibitions. In the α-amylase assay, 
the fraction compete favorably with acarbose, 
the significant effect was demonstrated by  
the acarbose at the lower concentrations  
(0.2, 0.4 mg/mL) and at the highest  
(1.0 mg/mL) in the percentage inhibition of 
the enzyme. The IC50 values of the fraction 
and acarbose were also significantly different 
at (P<0.05) (Table 4). 
 
 
Figure 5: Inhibitory potential of EFLC on α-amylase activity 
Values are mean ± standard deviation (SD) of triplicate determinations 
 
 
Figure 6: Inhibitory potential of EFLC on α-glucosidase activity 
Values are mean ± standard deviation (SD) of triplicate determinations. 
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Table 4: IC50 (mg/mL) values with R
2
 and Regression equation of EFLC on activities of alpha 
amylase and glucosidase 
 EFLC Acarbose 
 
𝛼-amylase 
IC50 0.73
 a
 0.57
 b
 
R
2
 0.9644 0.8868 
Regression equation Y=66.1450x +1.6890 Y=40.5750x+ 26.7550 
 
𝛼-glucosidase 
IC50 0.58
 a
 0.67
 b
 
R
2
 0.9814 0.8654 
Regression equation Y=75.7000x + 5.7240 Y=67.1850x +4.4890 
The values are expressed as mean of triplicate determinations.  Means along theRows not sharing a common 
superscript are significantly different (P<0.05) from each other.Acarbose is the standard antidiabetic agent. 
 
The Line weaver-Burk double reciprocal 
plot for the mechanism of inhibition showed 
that ethyl acetate fraction of LC inhibited  
α-amylase uncompetitively (Figure 7). The 
Vmax and Km values for the fraction are 
0.03 μM/min and 44.56 mg while that of 
control is 0.08 μM/min and 18.66, 
respectively. 
 
 
Figure 7: Lineweaver-Burk plot of EFLC eliciting uncompetitive inhibition on  
α-amylase activity 
Results represent mean ± standard deviation; (n=3); (P>0.05). 
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For α-glucosidase, the fraction exerts a 
significant dominating inhibitory activity  
on the enzyme at higher concentrations  
(0.6-0.8 mg/mL) in the percentage inhibition 
(Figure 6). Based on the IC50 value, EFLC 
exhibited a significant inhibitory effect on 
the enzyme when compared with acarbose 
(Table 4). Further probing into mechanism 
of inhibition showed that the fraction 
inhibited α-glucosidase non-competitively 
(Figure 8). The Vmax and Km values for the 
fraction are 0.12 μM/min and 31.50 mg 
while that of control is 0.04 μM/min and 
34.86 respectively. 
 
 
Figure 8: Lineweaver-Burk plot of EFLC eliciting non-competitive inhibition on α-glucosidase 
activity 
Results represent mean ± standard deviation; (n=3); (P>0.05). 
 
DISCUSSION 
DM is a metabolic disorder characteristic 
of carbohydrate metabolism, manifested by 
hyperglycemia or increased blood glucose 
level resulting from insulin deficiency.
32
 
Recently, herbal plants have been employed 
in the management of DM and are known as 
important source of novel antidiabetic 
agents.
33
 Antidiabetic herbal plants elicit  
their activities by inhibiting carbohydrate-
hydrolyzing inhibotors (α-amylase and 
glucosidase). The α-glucosidase inhibitors 
delay the uptake of absorbed carbohydrates 
that help to reduce PP sugar and insulin 
peaks.
34
 
In the present study, EFLC displayed a 
very significant potent and mild inhibitory 
effect on α-glucosidase and α-amylase 
respectively judging from its IC50 when 
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compared with the standard. The mild 
inhibitory activity of the fraction is desirable 
of good antidiabetic agent. Side effects such 
as abdominal distention, hypoglycemia and 
abnormal bacterial fermentation of undigested 
carbohydrates in the colon is always 
associated with immoderate inhibition of 
pancreatic 𝛼-amylase.28,35 Lineweaver- Burk 
plot also showed that EFLC inhibit  
𝛼-amylase uncompetitively. This implies 
that the fraction binds exclusively to the 
enzyme-substrate complex resulting to an 
inactive enzyme-substrate-inhibitor complex 
and this will consequently delay the 
digestion of carbohydrate and causing 
reduced glucose absorption rate.
28,36,37 
As for 𝛼-glucosidase, the EFLC 
demonstrates a significant potent inhibition 
towards the activity of the enzyme when 
compared with acarbose. Strong inhibition 
of this enzyme has been known to be a very 
proactive and effective therapy for control of 
PP hyperglycemia which is exhibited by  
this plant. This is due to the fact that  
𝛼-glucosidase inhibitors have ability to 
retard sugar absorption speed and the PP 
blood glucose level. Therefore, its inhibition 
is an important approach for the regulation 
of PP hyperglycemia.
38
 The non-competitive 
mechanism of inhibition displayed by EFLC 
on a-glucosidase implies that components in 
the fraction do not compete with the 
substrate for binding to the active site rather 
the inhibitors bind to a separate site on the 
enzyme to retard the conversion of 
disaccharides to monosaccharides.
39,40 
Induction of oxidative stress is a main 
process in the commencement of diabetic 
complications and various antioxidants have 
been developed recently to manage oxidative 
stress in diabetic patients.
11
 In this study, the 
EFLC displayed a good radical scavenging in 
all the antioxidant assays studied confirming 
EFLC as a potential source of antioxidants. 
Therefore, the antidiabetic potency exhibited 
by the EFLC may be related to its high 
antioxidant activity, thereby mopping up free 
radicals generated by diabetes-induced 
hyperglycemia.
41
 However, it could also play 
an important role in the prevention of 
physiological stress generated by free 
radicals when used to treat DM. 
Since the bioactivity of plant products 
mainly depends on the amount of the major 
active constituents, the 𝛼-amylase and 
glucosidase inhibitory activities exhibited by 
this plant may be due to the presence of 
phytochemicals such as alkaloid, flavonoid, 
cardiac glycoside, saponin, phenol and 
phytosterol. Moreover, phyto-constituents 
such as flavonoids and phenolic derivatives 
are known to boost the insulin secretion and 
also to preserve β-cell integrity and by 
mopping up free radicals in the system.
42,43
 
 
CONCLUSIONS 
Conclusively, the EFLC possesses  
𝛼-amylase and glucosidase modulatory 
activities which are two key enzymes that is 
linked to carbohydrate metabolism in  
the body, these attribute may be due to  
the presence of phytochemicals of 
pharmacological importance in EFLC. 
However, this study has once again 
demonstrated the efficacy of botanicals in 
the management of DM. 
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